Cardiovascular Information Center Archive
Higher-potency statins increased hospitalization for community-acquired pneumonia compared with lower-potency statins.
The AHA found that irregular eating patterns are less ideal for maintaining body weight and cardiometabolic health.
Diabetes without insulin did not appear to increase thromboembolic risk in patients with atrial fibrillation treated with anticoagulation.
RASIs reduced cardiovascular events and death only when compared with placebo but not when compared with active controls.
The device has shut down due to an intermittent connection between the battery and electrical contacts.
An estimated 12.3% of Americans over the age of 21 have masked hypertension.
Researchers observed a connection between advancing age, systemic inflammation, cardiovascular disease, and caffeine.
The ACP and the AAFP has released a joint recommendation for the pharmacologic treatment of hypertension in adults aged 60 years and older.
Individuals who perform their physical activity in 1 or 2 sessions during the week can still reduce their risk of mortality.
Prescription rates for statins were dependent on age among patients with severe dyslipidemia.
Researchers examined the association between statin use and the risk of uterine fibroids and fibroid-related symptoms.
The use of a decision aid in patients at risk of acute coronary syndrome increased patient knowledge about their risk.
Depending on race, sex, and ethnicity, the right statin type may lower the risk of Alzheimer disease.
Drinking small amounts of alcohol may increase the risk of atrial fibrillation.
Researchers sought to determine the risk of venous thromboembolism associated with use of testosterone treatment.
The prevalence of elevated blood pressure rates shifted from high-income to low- and middle-income countries.
Patients who also took either lovastatin or simvastatin had a 40% higher risk of major hemorrhage than those who took other statins.
The AHA/ACC guideline updates the 2005 recommendations on PAD management.
The reduction in thromboembolism was attenuated after accounting for competing death events.
PCSK9 inhibition produces incremental benefits on coronary disease progression in patients treated with statins.
The task force finalizes recommendations for statin therapy among adults between 40 and 75 years of age.
Ambulatory high-dose intravenous diuretic therapy could be cost saving compared with hospitalization for intravenous loop diuretic therapy.
Caffeine consumption in patients with systolic heart failure does not induce arrhythmias both at rest and during physical exercise.
One in 6 patients hospitalized for a first episode of syncope experiences a pulmonary embolism.
Depression can occur in approximately 1 in 5 patients who have chronic stable angina.
The AABB evaluated studies that examined hemoglobin thresholds for red blood cell transfusion and red blood cell storage duration.
Some individual NSAIDs may be linked to increased risk of hospital admission for heart failure.
Researchers observed significant improvement in LDL cholesterol in those at risk for diabetes.
Statin-based therapy had a smaller effect in reducing major vascular events in patients with advanced chronic kidney disease.
Researchers found that dietary changes, other medications, and surgery can also lower cardiovascular risk.
Researchers observed a lower frequency of statin recommendation with ESC guidelines compared with the AHA/ACC guidelines.
Foods fortified with folic acid are associated with a decrease in infants being born with congenital heart defects.
Patients with obstructive sleep apnea did not have reduced cardiovascular events after CPAP in addition to usual care.
A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.
The American Heart Association has released a science advisory regarding the cardiovascular risks associated with sedentary behavior.
Current evidence is insufficient to weigh the balance of benefits and harms of screening.
Patients with type 2 diabetes with systolic blood pressure lower than 140 mm Hg have a lower risk of cardiovascular events.
The American Heart Association has published a scientific statement that outlines which medications cause or exacerbate heart failure.
At 16 months, 30.3% of patients either died or experienced worsening heart failure.
Specific patient characteristics predicted the type of therapy more likely to be prescribed.
Readmission was more common among publically insured, black patients presenting with comorbidities including hypertension and diabetes.
Reductions in disease risk were observed for an intake as high as 7.5 servings of whole grains per day.
Coronary artery bypass surgery may lead to metabolic changes, causing new-onset diabetes.
The HEART pathway app provides doctors in the ED with a digital application an already proven method of assessment.
Non-vitamin K antagonist oral anticoagulants perform similarly to warfarin for patients with atrial fibrillation.
Researchers found that mortality rates dropped less than 1% between 2011 and 2014.
Incident events were most common in those within the lowest tertile of basline ALT serum.
Baseline renal function tests may predict the risk of preeclampsia and preterm birth for pregnant women with hypertension.
For patients with intracerebral hemorrhage, intensive blood pressure reduction has similar outcomes compared with standard treatment.
The FDA warns that the antidiarrheal loperamide can lead to serious cardiac events when taken in high doses.
Antiretroviral therapy in HIV-positive patients did not decrease the progression of arterial inflammation.
Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptives
Compared with other estrogen doses and progestogen types, low-dose estrogen with levonorgestrel had a decreased risk of adverse events.
Women who experience migraines had a 50% greater risk for developing major CVD.
Aspirin significantly reduces the risk of a recurrent stroke 6 weeks after a transient ischemic attack or minor stroke.
Even those who are in overall poor health and medically frail could benefit from hypertension interventions.
The link is elevated in women 40 years of age or younger.
Deferred defibrillation was not associated with improved survival.
Study results showed a higher risk of CHD in women who work rotating night shifts.
Women who had gestational diabetes may be able to reduce their risk of developing hypertension by eating a healthy diet.
Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients
Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.
Patients with psoriasis are more likely to have an abdominal aortic aneurysm, with the likelihood increasing with more severe psoriasis.
The USPSTF concluded that a low-dose aspirin regimen can prevent cardiovascular disease and colorectal cancer in adults aged 50 to 59.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
Patients with coronary artery disease who were previously not considered candidates for CABG may benefit from the surgery.
Regardless of history of heart failure, incretin-based medications are not associated with an increased risk for hospitalization due to heart failure.
Training the public in bystander CPR and first responder defibrillation improves outcomes for cardiac arrest that occurs outside of a hospital.
Results from a study presented at ACC in Chicago suggest that statins can be more widely used in patients considered to be intermediate risk for cardiovascular disease.
A large study found that use of SSRI medications to treat depression does not increase the risk of cardiovascular events in patients 20 to 64 years of age.
Electronic consultation between PCPs and specialists can resolve cases faster than if a patient followed up with a specialist themselves.
Women and men experience different symptoms, risks, and outcomes of myocardial infarction.
Patients who were obese and underwent bariatric surgery saw a significant reduction in heart failure-related exacerbation events.
Current evidence is inadequate to determine how DPP-4 inhibitors affect the risk of heart failure in patients with type 2 diabetes.
Renin angiotensin system blockers have similar risks and outcomes compared with other antihypertensive agents for patients with diabetes.
Although pioglitazone decreased the risk of stroke and myocardial infarction in this population, it elevated the risk of weight gain, edema, and bone fracture.
Cardiovascular deaths have significantly decreased among people with rheumatoid arthritis.
A one-point increase in the American Heart Association's Life's Simple 7 checklist correlated to a 23% lower risk of developing heart failure.
After adult cardiac surgery, patients are less likely to be readmitted to the hospital if they receive house calls from PAs.
Women with atrial fibrillation are at higher risk for cardiovascular disease, stroke, and death.
Patients with heart failure who receive the influenza vaccine may have a lower risk for all-cause mortality compared with those who do not get the vaccine.
Investigators found an increased risk of ischemic stroke among all patients within 21 days following initiation of alpha-blocker therapy.
Researchers found a 15% to 20% reduction in the risk of hospitalization for or death from heart failure in patients who received cardiac resynchronization therapy with defibrillator (CRT-D).
Premature birth has been associated with a number of adverse health conditions.
Chronic heart failure patients who restrict sodium intake may have an increased risk of death or hospitalization.
Treating hypertension can reduce the risk of major cardiovascular disease events regardless of blood pressure at the start of treatment.
The FDA has approved Uptravi (selexipag) for the treatment of pulmonary arterial hypertension in adult patients.
Stroke risk increased for three months immediately following a shingles diagnosis, with a two-fold risk during the first week.
Even after adjusting for obesity, researchers discovered that children with allergic diseases may double their risk of hypertension, hyperlipidemia, and other related cardiovascular diseases.
To combat the stigma associated with selective screening, the American Academy of Pediatrics has called for all children to be screened for high cholesterol, depression, and HIV.
A CDC team analyzed national data from 2005 through 2014 and discovered that 35% of Americans eligible to take cholesterol-lowering medication were not taking the drugs.
Researchers have linked pulse pressure to adverse outcomes in heart failure patients with both reduced ejection fraction and preserved ejection fraction.
New guidelines released by the American Heart Association and the American Thoracic Society are the first for the diagnosis and treatment of pediatric pulmonary hypertension.
Both women and young patients are often unaware that they have modifiable cardiac risk factors.
Researchers examined the effectiveness of diuretic treatment for volume management in patients with chronic heart failure and evidence of worsening congestion.
Sitting for prolonged periods of time is linked to worse health in patients with coronary artery disease.
Women with a higher body mass index (BMI) in early adulthood were at an elevated risk of sudden cardiac death and coronary heart disease.
Researchers on the BEAT-HF trial have concluded that, in patients with chronic heart failure, mirabergron failed to improve left ventricular ejection fraction.
Reducing blood pressure to a lower level than recommended in hypertension guidelines may further decrease the risk of heart attack and stroke.
In the past 20 years, the number of American adults who have achieved ideal cardiovascular health has decreased.
Vericiguat well tolerated but not statistically significant in reducing natriuretic peptide level in patients with chronic heart failure
A phase 2 trial of the drug vericiguat did not show a statistically significant reduction of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in patients with worsening chronic heart failure.
Elevated total bilirubin, transaminases reported in chronic heart failure patients with poor prognosis
Researchers evaluate the echocardiographic correlates of elevated total bilirubin and transaminases in patients with chronic heart failure.